Lipoprotein (Sub)Fraction Analysis on the Bruker B.I. LISA Platform

Area of Science:

• Clinical Chemistry
• Biomarker Analysis
• Lipidomics

Background:

• Lipoprotein analysis is crucial for understanding cardiovascular disease risk.
• Accurate quantification of lipoprotein subclasses and their lipid content is essential.
• Existing methods may lack the precision and reproducibility required for clinical applications.

Purpose of the Study:

• To describe the standardized B.I. Methods protocol for the Bruker B.I. LISA platform.
• To ensure users can obtain quantitative and reproducible lipoprotein analysis data.
• To detail the steps for analyzing main lipoprotein classes and their subfractions.

Main Methods:

• The B.I. LISA platform utilizes a specific protocol, the B.I. Methods.
• The protocol involves detailed steps for sample preparation and analysis.
• Standard operating procedures are critical for consistent data generation.

Main Results:

• The B.I. Methods protocol enables detailed analysis of lipoprotein particle numbers and lipids.
• Data includes major lipoprotein classes (VLDL, IDL, LDL, HDL) and their subfractions.
• The protocol is designed for quantitative and reproducible results.

Conclusions:

• Adherence to the B.I. Methods protocol is essential for accurate lipoprotein analysis using the B.I. LISA platform.
• The described protocol facilitates reliable quantification of lipoprotein subclasses.
• This standardized approach supports robust biomarker discovery and clinical diagnostics.